The global Antisense Therapy market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of genetic disorders and improve patient outcomes. The market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2035, growing at a CAGR of 6.6%.
The Antisense...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek